19 March 2010

Collaboration for Neuropharm

20/09/2007 Robert Tyerman

Autism treatment developer Neuropharm is advancing through collaboration after losing an annual £3.2 million.

Berkshire-based Neuropharm, which floated on AIM in March with a £20 million placing, spent £1.3 million on research and development and £1.7 million on management and administration in the year to June. The company, whose key project is NPL-2008, an autism treatment using a formulation of the genetic compound fluoxetine, is progressing towards its US registration through a series of collaborative deals.

Collaboration partners include Autism Speaks, the world's largest autism patients' organisation, the Fragile X Research Foundation and Catalent Pharma. Chairman Graeme Hart and chief executive officer Robert Mansfield say Neuropharm is on track to seek approval from the US Food & Drug Administration in the fourth quarter of next year, for a product launch towards the end of 2009 at the earliest.

The company is also working on other potential products in the field of neuro-developmental disorders. Floated at 127p, the shares now trade at 187p, valuing the company at £59 million, and should have further to go if the treatments work out.

Growth Company Investor subscribers have full access to all our AIM and small-cap share recommendations. To subscribe today, and gain immediate access, click here or on the following link:
www.growthcompany.co.uk/offers/GCI/ARTICLEEND07

Sector: Pharmaceuticals & Biotechnology

Companies: Neuropharm

Subscribe today

£7,277

That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.

Subscribe now and receive a 50% discount

AIM in Review 2010

Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Directors' Pay on AIM 2009 – ­ a Growth Company Investor publication in association with Deloitte

The report reveals the top-earning chief executives and remuneration levels at AIM's most profitable and fastest-growing companies. It also examines constituent parts, including basic salary, bonus, pensions, benefits and share-based payments. To order click here.

Free – Latest Stock Recommendations

Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.

Select your level of risk and we select the funds

Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.

The AIM Guide 2009/10

The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies.   Order your copy today and benefit from a £10 discount!

VCT Special Report 2009

This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.

Cash Shells Special Report 2009

Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Record output at Cluff 19/03/2010

Potential bid candidate Cluff Gold produced 19,288 oz of gold in West Africa in the first two months of the year.

Tags: AIM , Cash , Commodities

Sector: Mining

Companies: Cluff Gold

Brainspark takes football stake 19/03/2010

As foreshadowed in the latest Growth Company Investor, investment minnow Brainspark is buying into Italian football club AC Ancona.

Tags: AIM , Deals & contracts , Fundraisings

Sector: General Financial

Companies: Brainspark

Avocet targets growth after setback 18/03/2010

Gold producer Avocet Mining hopes its Wega acquisition will take 2010 group output to 200,000 oz after a flat nine months.

Tags: AIM , Commodities , Mergers & acquisitions

Sector: Mining

Companies: Avocet Mining

More News

Sectors

Vitesse Media Events